JCOVDEN
8,92LOG10INF.U/0,5ML INJ SUS 20X2,5ML
| SÚKL code | 0255009 |
|---|---|
| Name of the product | JCOVDEN |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | JCOVDEN |
| Supplement | 8,92LOG10INF.U/0,5ML INJ SUS 20X2,5ML |
| Strenght | 8,92LOG10INF.U/0,5ML |
| Pharmaceutical form | Suspension for injection |
| Package | 20X2,5ML |
| Route | Intramuscular use |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance | CCOVID-19 (AD26.COV2-S) RECOMBINANT VACCINE (COVID-19 (AD26.COV2-S) RECOMBINANT VACCINE) |
| ATC group | J07BX03 |
| ATC group name | VAKCÍNY PROTI COVID-19 |
Marketing authorisation information
| Registration Number | EU/1/20/1525/002 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Janssen-Cilag International N.V., Beerse |
| MA Holder country | BELGIE |
cz